Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Mathian

Showing results (101-110 of 212) with videos related to

Pageof 22
Sort By:
Journal of the American Academy of Dermatology|September 6, 2025
Predictors of response to anifrolumab in cutaneous lupus erythematosus: a prospective cohort study of 57 PatientsJeanne de La Rochefoucauld, Alexandre Teboul, Nassim Ait Abdallah, et al.
The Journal of Clinical Psychiatry|December 8, 2022
Factors Associated With Posttraumatic Stress Symptoms 3 and 6 Months After Hospitalization for COVID-19: A Longitudinal Multicenter StudyVictor Pitron, Willys Cantenys, Anne Herbelin, et al.
EULAR Rheumatology Open|June 29, 2026
Association between cumulative glucocorticoid exposure and epicardial adipose tissue volume in systemic lupus erythematosusLévi-Dan Azoulay, Nadjia Kachenoura, Samia Boussouar, et al.
Orphanet Journal of Rare Diseases|May 7, 2013
Lupus enteritis: from clinical findings to therapeutic managementPeter Janssens, Laurent Arnaud, Lionel Galicier, et al.
Journal of the American Academy of Dermatology|January 24, 2025
Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: A monocentric study of 184 patientsQuitterie Murat de Montai, Clémence Masseran, Laura Perray, et al.
European Journal of Immunology|September 11, 2015
Ultraviolet light converts propranolol, a nonselective β-blocker and potential lupus-inducing drug, into a proinflammatory AhR ligandKarim Dorgham, Zahir Amoura, Christophe Parizot, et al.
Autoimmunity Reviews|December 3, 2014
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodiesLaurent Arnaud, Alexis Mathian, Hervé Devilliers, et al.
Journal of the American Academy of Dermatology|February 1, 2024
Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patientsClémence Masseran, Laura Perray, Quitterie Murat de Montai, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 28, 2017
Successful outcome of proliferative lupus nephritis during pregnancy: Toward a modern paradigm of lupus pregnancy?François-Xavier Danlos, Fleur Cohen Aubart, Danièle Vauthier-Brouzes, et al.
Journal of Neurology|March 6, 2017
Long-term outcomes of refractory neurosarcoidosis treated with infliximabFleur Cohen Aubart, Diane Bouvry, Damien Galanaud, et al.
Pageof 22

Showing results (101-110 of 212) with videos related to

Sort By:
Pageof 22
Journal of the American Academy of Dermatology|September 6, 2025
Predictors of response to anifrolumab in cutaneous lupus erythematosus: a prospective cohort study of 57 PatientsJeanne de La Rochefoucauld, Alexandre Teboul, Nassim Ait Abdallah, et al.
The Journal of Clinical Psychiatry|December 8, 2022
Factors Associated With Posttraumatic Stress Symptoms 3 and 6 Months After Hospitalization for COVID-19: A Longitudinal Multicenter StudyVictor Pitron, Willys Cantenys, Anne Herbelin, et al.
EULAR Rheumatology Open|June 29, 2026
Association between cumulative glucocorticoid exposure and epicardial adipose tissue volume in systemic lupus erythematosusLévi-Dan Azoulay, Nadjia Kachenoura, Samia Boussouar, et al.
Orphanet Journal of Rare Diseases|May 7, 2013
Lupus enteritis: from clinical findings to therapeutic managementPeter Janssens, Laurent Arnaud, Lionel Galicier, et al.
Journal of the American Academy of Dermatology|January 24, 2025
Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: A monocentric study of 184 patientsQuitterie Murat de Montai, Clémence Masseran, Laura Perray, et al.
European Journal of Immunology|September 11, 2015
Ultraviolet light converts propranolol, a nonselective β-blocker and potential lupus-inducing drug, into a proinflammatory AhR ligandKarim Dorgham, Zahir Amoura, Christophe Parizot, et al.
Autoimmunity Reviews|December 3, 2014
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodiesLaurent Arnaud, Alexis Mathian, Hervé Devilliers, et al.
Journal of the American Academy of Dermatology|February 1, 2024
Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patientsClémence Masseran, Laura Perray, Quitterie Murat de Montai, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 28, 2017
Successful outcome of proliferative lupus nephritis during pregnancy: Toward a modern paradigm of lupus pregnancy?François-Xavier Danlos, Fleur Cohen Aubart, Danièle Vauthier-Brouzes, et al.
Journal of Neurology|March 6, 2017
Long-term outcomes of refractory neurosarcoidosis treated with infliximabFleur Cohen Aubart, Diane Bouvry, Damien Galanaud, et al.
Pageof 22